Interferon-induced modulation of human ras oncogene expression

Progress in Clinical and Biological Research
|January 1, 1985
PubMed

Insights

Interferon (IFN) treatment reversed ras oncogene-induced cell transformation. This resulted in reverted tumor cells with normal morphology and growth, demonstrating reduced oncogene expression.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cell transformation by oncogenes like c-Ha-ras1 drives cancer development.
  • Interferon (IFN) is known for its anti-proliferative and anti-viral effects.
  • Understanding how IFN impacts oncogene expression is crucial for cancer therapy.

Purpose of the Study:

  • To investigate the effect of interferon (IFN) on ras oncogene-induced cell transformation.
  • To analyze the impact of IFN on oncogene expression in established tumor cells.

Main Methods:

  • NIH 3T3 cells were transfected with human bladder carcinoma c-Ha-ras1 oncogene DNA.
  • Transfected cells and an established tumor line (RS485) were treated with IFN.
  • Phenotypic reversion, cell morphology, growth characteristics, soft agar colony formation, and tumorigenicity in nude mice were assessed.
  • Levels of c-Ha-ras1 mRNA and the onc-encoded protein p21 were quantified.

Main Results:

  • IFN treatment inhibited ras-induced cell transformation in NIH 3T3 cells.
  • IFN treatment of RS485 tumor cells led to the emergence of reverted colonies with normal morphology and growth.
  • Revertant cells exhibited contact inhibition, failed to grow in soft agar, and were non-tumorigenic in nude mice.
  • Revertant cells showed significantly decreased levels of c-Ha-ras1 mRNA and p21 protein compared to parental RS485 cells, despite retaining the transfected oncogene.

Conclusions:

  • Interferon (IFN) can reverse oncogene-induced cell transformation and suppress the malignant phenotype.
  • IFN treatment downregulates the expression of the c-Ha-ras1 oncogene and its encoded protein p21.
  • These findings suggest a potential therapeutic role for IFN in cancers driven by ras oncogene activation.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...